Overview

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Status:
Completed
Trial end date:
2020-03-03
Target enrollment:
Participant gender:
Summary
A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.
Phase:
Phase 2
Details
Lead Sponsor:
Foamix Ltd.
Vyne Therapeutics Inc.
Treatments:
Adapalene
Minocycline